Search research articles
Contact Us
Filters
Showing results (61-70 of 212) with videos related to
Page
of 22
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 16, 2019
Safety of Inactivated Influenza Vaccine in Cancer Patients Receiving Immune Checkpoint Inhibitors
Curtis R Chong, Vivian J Park, Bevin Cohen, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
May 8, 2026
A Multidisciplinary Approach to Checkpoint Inhibitor Adverse Reactions
Courtney N Andrews, Eric M Mukherjee, Andrew Gibson, et al.
The Oncologist
|
November 2, 2022
Associations Between Race/Ethnicity, Language, and Enrollment on Cancer Research Studies
Ogochukwu M Ezeoke, Gary Brooks, Michael A Postow, et al.
JAMA Dermatology
|
January 10, 2019
Evaluation of the Response of Unresectable Primary Cutaneous Melanoma to Immunotherapy Visualized With Reflectance Confocal Microscopy: A Report of 2 Cases
Cristian Navarrete-Dechent, Miguel Cordova, Michael A Postow, et al.
The Oncologist
|
September 18, 2023
Prevalence of Enteric Infections in Patients on Immune Checkpoint Inhibitors and Impact on Management and Outcomes
Patrick T Magahis, Deepika Satish, Ngolela Esther Babady, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine
|
May 6, 2018
Immune-related Adverse Events in Cancer Patients
Daniel J Pallin, Christopher W Baugh, Michael A Postow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 2015
Safety of Infusing Ipilimumab Over 30 Minutes
Parisa Momtaz, Vivian Park, Katherine S Panageas, et al.
Journal of the American Academy of Dermatology
|
May 29, 2020
Immune checkpoint inhibitors to treat cutaneous malignancies
Dulce M Barrios, Mytrang H Do, Gregory S Phillips, et al.
Melanoma Research
|
August 20, 2019
Absolute lymphocyte count as a prognostic biomarker for overall survival in patients with advanced melanoma treated with ipilimumab
Michael A Postow, Scott D Chasalow, Deborah Kuk, et al.
Biorxiv : the Preprint Server for Biology
|
May 10, 2023
Uncovering the hidden structure of dynamic T cell composition in peripheral blood during cancer immunotherapy: a topic modeling approach
Xiyu Peng, Jasme Lee, Matthew Adamow, et al.
Page
of 22
Search research articles
Search
Showing results (61-70 of 212) with videos related to
Sort By:
Page
of 22
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 16, 2019
Safety of Inactivated Influenza Vaccine in Cancer Patients Receiving Immune Checkpoint Inhibitors
Curtis R Chong, Vivian J Park, Bevin Cohen, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
May 8, 2026
A Multidisciplinary Approach to Checkpoint Inhibitor Adverse Reactions
Courtney N Andrews, Eric M Mukherjee, Andrew Gibson, et al.
The Oncologist
|
November 2, 2022
Associations Between Race/Ethnicity, Language, and Enrollment on Cancer Research Studies
Ogochukwu M Ezeoke, Gary Brooks, Michael A Postow, et al.
JAMA Dermatology
|
January 10, 2019
Evaluation of the Response of Unresectable Primary Cutaneous Melanoma to Immunotherapy Visualized With Reflectance Confocal Microscopy: A Report of 2 Cases
Cristian Navarrete-Dechent, Miguel Cordova, Michael A Postow, et al.
The Oncologist
|
September 18, 2023
Prevalence of Enteric Infections in Patients on Immune Checkpoint Inhibitors and Impact on Management and Outcomes
Patrick T Magahis, Deepika Satish, Ngolela Esther Babady, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine
|
May 6, 2018
Immune-related Adverse Events in Cancer Patients
Daniel J Pallin, Christopher W Baugh, Michael A Postow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 2015
Safety of Infusing Ipilimumab Over 30 Minutes
Parisa Momtaz, Vivian Park, Katherine S Panageas, et al.
Journal of the American Academy of Dermatology
|
May 29, 2020
Immune checkpoint inhibitors to treat cutaneous malignancies
Dulce M Barrios, Mytrang H Do, Gregory S Phillips, et al.
Melanoma Research
|
August 20, 2019
Absolute lymphocyte count as a prognostic biomarker for overall survival in patients with advanced melanoma treated with ipilimumab
Michael A Postow, Scott D Chasalow, Deborah Kuk, et al.
Biorxiv : the Preprint Server for Biology
|
May 10, 2023
Uncovering the hidden structure of dynamic T cell composition in peripheral blood during cancer immunotherapy: a topic modeling approach
Xiyu Peng, Jasme Lee, Matthew Adamow, et al.
Page
of 22